Managing the Side Effects of Psychotropic Medications, Second Edition

2019 ◽  
Vol 25 (5) ◽  
pp. 411-413
Author(s):  
Richard Balon
2003 ◽  
Vol XXXV (1-2) ◽  
pp. 39-43
Author(s):  
A. V. Kuchaeva ◽  
L. E. Ziganshina ◽  
K. K. Yakhin ◽  
L. M. Minnetdinova ◽  
F. F. Gatin ◽  
...  

During pharmacotherapy with neuroleptics of paranoid schizophrenia patients there had been studied retrospectively and perspectively frequency and expressiveness of side effects. There was determined a correlation between neuro-motor reaction expressiveness of neuroleptics and sex, age and time of intake. The obtained results can be very useful to a practioner for his/ her rational usage of psychotropic medications, removal of neuro- motor reaction and making decision in continuation of neuroleptic therapy.


2008 ◽  
Vol 55 (3) ◽  
pp. 89-99 ◽  
Author(s):  
Daniel E. Becker

Abstract Appropriate preoperative assessment of dental patients should always include analysis of their medications. Psychiatric illnesses including panic/anxiety disorder, depression, psychoses, and manic disorders are prevalent within our society. An impressive number of drug formulations are prescribed for these disorders, and they introduce concern regarding side effects and possible drug interactions with medications the dentist may deem necessary for dental care. This article will address essential pharmacology of these psychotropic medications.


2006 ◽  
Vol 28 (3) ◽  
pp. 218-240 ◽  
Author(s):  
H. Gray Otis ◽  
Jason H. King

Research from a variety of sources demonstrates that psychotropic medications have induced a number of unanticipated physiological and psychological client reactions. Although a great deal of literature is published concerning potential expected side effects from psychotropic medications, little is understood regarding other unexpected reactions that may cause significant client discomfort. These unanticipated psychotropic reactions may be considered as effects that may be rare and therefore not accounted for in randomized clinical drug trials. Like any medication, psychotropic medications do not produce the same effect in everyone. Some people may respond better to one medication than another. Mental health counselors are advised to be aware that some unexpected reactions can be important in determining client outcomes. In this article, we discuss the client's right to be informed about unanticipated side-effects of their medication regimen and the ethical question as to how much information to give clients.


1997 ◽  
Vol 42 (3) ◽  
pp. 1-6 ◽  
Author(s):  
Donald Addington ◽  
Richard Williams ◽  
Yvon Lapierre ◽  
Nady El-Guebaly

This paper represents the position of the Canadian Psychiatric Association on the ethical and scientific issues related to the use of placebos in the evaluation of new psychotropic drugs. The position taken by the Association is that new psychotropic medications must be shown to be effective and must be weighed against the best current interventions. Placebo controls may be appropriate under certain circumstances, even when an established intervention is effective. These include situations in which placebo response rates are high, variable, or close to response rates for effective therapies. Placebo controls arc also appropriate when established interventions cany a high risk of side effects or are effective against only certain symptoms of the disorder.


2006 ◽  
Vol 28 (4) ◽  
pp. 309-337 ◽  
Author(s):  
Thomas L. Murray, Jr.

A number of literature reviews exist that support the use of psychotropic medications. This article provides a review of the disconfirming literature regarding psychopharmacology use. Comparing the first review of psychopharmacology published in the counseling field two decades earlier to what is known currently, I examine recent developments in psychopharmacology research focusing on the safety, efficacy, side-effects, and theoretical assumptions of various classes of psychotropic medications. This article concludes by addressing counselor identity, practice and training concerns vis-à-vis psychiatric medications and the medical model.


2014 ◽  
Vol 55 (1) ◽  
pp. 1-20 ◽  
Author(s):  
Mario V. Mitkov ◽  
Ryan M. Trowbridge ◽  
Benjamin N. Lockshin ◽  
Jason P. Caplan

2013 ◽  
Vol 27 (7) ◽  
pp. 616-628 ◽  
Author(s):  
Alessandro Serretti ◽  
Alberto Chiesa ◽  
Raffaella Calati ◽  
Chiara Fabbri ◽  
Othman Sentissi ◽  
...  

2018 ◽  
Vol 6 (3) ◽  
pp. 8 ◽  
Author(s):  
Caroline Kinskey ◽  
Jeffrey A. Buchanan

Aggression is a common behavior in persons with dementia (PWDs). Nursing staff report that aggression is the most distressing behavior they face on the job. In addition, aggression may result in the prescription of psychotropic medications, which are largely ineffective and have dangerous side effects. Therefore, non-pharmacological interventions are necessary to safely manage aggressive behaviors and target the underlying cause of aggression. The current paper is a 10-year follow-up to Buchanan and colleagues’ 2007 literature review of non-pharmacological interventions for aggression in PWDs. This paper has three primary purposes: (1) To update the review of the empirical literature in this area; (2) To examine how limitations in the literature have been addressed over the past 10 years; and (3) To suggest areas of future inquiry. Findings suggest that comprehensive staff training interventions and distraction-based interventions during activities of daily living (ADLs) show the most promise for managing aggression in PWDs.


Sign in / Sign up

Export Citation Format

Share Document